Herbert Lepor, MD, presented “Is Focal Ablation of Prostate Cancer Ready for Prime Time?” during the Jackson Hole Seminars on February 7, 2018, in Jackson Hole, Wyoming.
How to cite: Lepor, Herbert. “Is Focal Ablation of Prostate Cancer Ready for Prime Time?” February 7, 2018. Accessed Nov 2024. https://dev.grandroundsinurology.com/is-focal-ablation-of-prostate-cancer-ready-for-prime-time/
Is Focal Ablation of Prostate Cancer Ready for Prime Time?
Summary:
Herbert Lepor, MD, defines focal ablation for prostate cancer and its quality of life, oncological, and cost benefits to patients. He then discusses best practices for the procedure, including optimal patient selection, energy source options, and extent of the ablation zone. Furthermore, he explains the research and improvement needed to make focal ablation ready for prime time.
ABOUT THE AUTHOR
Dr. Herbert Lepor serves as a Professor of Urology, Biochemistry, and Molecular Pharmacology and as the Martin Spatz Chairman of the Department of Urology at NYU Langone Health in New York City. His clinical practice is devoted exclusively to the surgical management of prostate cancer. He also serves as Chairman of the Scientific Advisory Board at UroGen Pharmaceuticals, Ltd., and has served as a member of the Medical Advisory Board at Skyline Medical, Inc. He has served on the editorial boards of several major urological journals and has authored several hundred peer-reviewed articles, along with numerous book chapters and books.
